Msci Inc. provides investment decision support tools worldwide, including indexes, portfolio risk and performance analytics, and multi-asset class market risk analytics products and services. The company was founded in 1998 and is based in New York, New York.
MSCI Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for MSCI Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that MSCI Inc ranked in the 30th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for MSCI, they are:
91% of the company's capital comes from equity, which is greater than 74.38% of stocks in our cash flow based forecasting set.
Relative to other stocks in its sector (Financial Services), MSCI Inc has a reliance on debt greater than only 20.67% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of MSCI Inc? See WTRE, FDS, MORN, SCU, and WDR.
How factor investing is reinventing asset allocation Submitted 26/01/2021 - 4:41pm For long-term investors, an unpredictable year in financial markets has underlined why it is more important than ever to understand the factors at work in their portfolios. Factor rotation was rapid in 2020: national lockdowns put pressure on value stocks, while returns on ‘momentum’ stocks soared thanks to the new era of working from home leaving technology companies largely unscathed. “Factors often provide answers, and what we found last year is that more and more investors were looking at factors in real time to try to understand the behaviour of markets and make decisions about how they might rebalance portfolios,” says Mark Carver (pictured), Global Head of Equity Factor Products at MSCI. This is pa...
MSCI Inc said it will remove five Chinese companies from its flagship global equity index as of the end of Jan. 27 in the absence of an update on a Trump administration order banning Americans from investing in certain Chinese companies.
(Bloomberg) -- India’s benchmark equity index fell, trimming the weekly gain as the nation prepares to start one of the world’s biggest inoculation programs on Saturday.The S&P BSE Sensex slipped 1.1%, closing at 49,034.67, cutting its advance this week to 0.5%. The measure’s pull-back comes after it rose within a whisker earlier this week of reaching the 50,000 level for the first time. The NSE Nifty 50 Index declined 1.1% Friday.“While we are seeing some kind of weakness, this doesn’t mean it is negative news per se, because earnings are going to be pretty good at least for next one or two quarters,” said Abhimanyu Sofat, head of research at IIFL Securities Ltd.India’s key stock gauges have touched successive new highs in recent weeks as foreign funds piled into the nation’s equities,...